BIO Reaches Out To China, Encourages Harmonization
This article was originally published in PharmAsia News
Executive Summary
WASHINGTON - Chinese officials are in the process of building the country's biotech regulatory framework, and foreign and domestic companies see opportunities to help shape the country's path toward becoming a major biotech market